Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2001 Mar 10

PMID 11238064

Citations 73

Authors

C Schwesinger

C Yee

R M Rohan

A M Joussen

A Fernandez

T N Meyer

V Poulaki

J J Ma

T M Redmond

S Liu

A P Adamis

R J DAmato

Affiliations

Soon will be listed here.

Abstract

Choroidal neovascularization in age-related macular degeneration is a frequent and poorly treatable cause of vision loss in elderly Caucasians. This choroidal neovascularization has been associated with the expression of vascular endothelial growth factor (VEGF). In current animal models choroidal neovascularization is induced by subretinal injection of growth factors or vectors encoding growth factors such as VEGF, or by disruption of the Bruch's membrane/retinal pigment epithelium complex with laser treatment. We wished to establish a transgenic murine model of age-related macular degeneration, in which the overexpression of VEGF by the retinal pigment epithelium induces choroidal neovascularization. A construct consisting of a tissue-specific murine retinal pigment epithelium promoter (RPE(65) promoter) coupled to murine VEGF(164) cDNA with a rabbit beta-globin-3' UTR was introduced into the genome of albino mice. Transgene mRNA was expressed in the retinal pigment epithelium at all ages peaking at 4 months. The expression of VEGF protein was increased in both the retinal pigment epithelium and choroid. An increase of intravascular adherent leukocytes and vessel leakage was observed. Histopathology revealed intrachoroidal neovascularization that did not penetrate through an intact Bruch's membrane. These results support the hypothesis that additional insults to the integrity of Bruch's membrane are required to induce growth of choroidal vessels into the subretinal space as seen in age-related macular degeneration. This model may be useful to screen for inhibitors of choroidal vessel growth.

Citing Articles

Exploring Current Molecular Targets in the Treatment of Neovascular Age-Related Macular Degeneration toward the Perspective of Long-Term Agents.

Fragiotta S, Bassis L, Abdolrahimzadeh B, Marino A, Sepe M, Abdolrahimzadeh S Int J Mol Sci. 2024; 25(8).

PMID: 38674018 PMC: 11050199. DOI: 10.3390/ijms25084433.

MicroRNA-126 (MiR-126): key roles in related diseases.

Liao L, Tang Y, Zhou Y, Meng X, Li B, Zhang X J Physiol Biochem. 2024; 80(2):277-286.

PMID: 38517589 DOI: 10.1007/s13105-024-01017-y.

Imaging Histology Correlations of Intraretinal Fluid in Neovascular Age-Related Macular Degeneration.

Berlin A, Messinger J, Balaratnasingam C, Mendis R, Ferrara D, Freund K Transl Vis Sci Technol. 2023; 12(11):13.

PMID: 37943552 PMC: 10637202. DOI: 10.1167/tvst.12.11.13.

Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods.

Bora K, Kushwah N, Maurya M, Pavlovich M, Wang Z, Chen J Cells. 2023; 12(20).

PMID: 37887287 PMC: 10605292. DOI: 10.3390/cells12202443.

Comparison between sodium iodate and lipid peroxide murine models of age-related macular degeneration for drug evaluation-a narrative review.

Kim S, Qian H Ann Eye Sci. 2023; 7.

PMID: 37622161 PMC: 10448775. DOI: 10.21037/aes-21-25.

References

Soubrane G, Cohen S, Delayre T, Tassin J, Hartmann M, Coscas G . Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig. Curr Eye Res. 1994; 13(3):183-95. DOI: 10.3109/02713689408995776. View

Orzalesi N, Migliavacca L, Miglior S . Subretinal neovascularization after naphthalene damage to the rabbit retina. Invest Ophthalmol Vis Sci. 1994; 35(2):696-705. View

Lutty G, McLeod D, Pachnis A, Costantini F, Fabry M, Nagel R . Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease. Am J Pathol. 1994; 145(2):490-7. PMC: 1887388. View

Seregard S, Algvere P, Berglin L . Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefes Arch Clin Exp Ophthalmol. 1994; 232(6):325-9. DOI: 10.1007/BF00175983. View

Kimura H, Sakamoto T, Hinton D, Spee C, Ogura Y, Tabata Y . A new model of subretinal neovascularization in the rabbit. Invest Ophthalmol Vis Sci. 1995; 36(10):2110-9. View

Reddy V, Zamora R, Kaplan H . Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1995; 120(3):291-301. DOI: 10.1016/s0002-9394(14)72158-0. View

ROBERTS W, Palade G . Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995; 108 ( Pt 6):2369-79. DOI: 10.1242/jcs.108.6.2369. View

Kvanta A . Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res. 1995; 14(11):1015-20. DOI: 10.3109/02713689508998523. View

Lopez P, Sippy B, Lambert H, Thach A, Hinton D . Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996; 37(5):855-68. View

10.

Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K . The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest. 1996; 74(4):819-25. View

11.

Shima D, Gougos A, Miller J, Tolentino M, Robinson G, Adamis A . Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci. 1996; 37(7):1334-40. View

12.

Tolentino M, Miller J, Gragoudas E, Chatzistefanou K, Ferrara N, Adamis A . Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol. 1996; 114(8):964-70. DOI: 10.1001/archopht.1996.01100140172010. View

13.

Kvanta A, Algvere P, Berglin L, Seregard S . Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996; 37(9):1929-34. View

14.

Melder R, Koenig G, Witwer B, Safabakhsh N, Munn L, Jain R . During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med. 1996; 2(9):992-7. DOI: 10.1038/nm0996-992. View

15.

Frank R, Amin R, Eliott D, Puklin J, Abrams G . Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 1996; 122(3):393-403. DOI: 10.1016/s0002-9394(14)72066-5. View

16.

Kuroki M, Voest E, Amano S, Beerepoot L, Takashima S, Tolentino M . Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 1996; 98(7):1667-75. PMC: 507601. DOI: 10.1172/JCI118962. View

17.

Tolentino M, Miller J, Gragoudas E, Jakobiec F, Flynn E, Chatzistefanou K . Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996; 103(11):1820-8. DOI: 10.1016/s0161-6420(96)30420-x. View

18.

Klagsbrun M, DAmore P . Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 1996; 7(3):259-70. DOI: 10.1016/s1359-6101(96)00027-5. View

19.

Thurston G, Baluk P, Hirata A, McDonald D . Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol. 1996; 271(6 Pt 2):H2547-62. DOI: 10.1152/ajpheart.1996.271.6.H2547. View

20.

Kliffen M, Sharma H, Mooy C, Kerkvliet S, de Jong P . Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997; 81(2):154-62. PMC: 1722110. DOI: 10.1136/bjo.81.2.154. View